688289 圣湘生物
已收盘 09-02 15:00:01
资讯
新帖
简况
圣湘生物:上半年流水线落地60余套
证券之星 · 08-31 15:37
圣湘生物:上半年流水线落地60余套
每周股票复盘:圣湘生物(688289)Q2净利降31.99%
证券之星 · 08-30
每周股票复盘:圣湘生物(688289)Q2净利降31.99%
圣湘生物(688289)2026年中报简析:净利润同比下降39.76%,公司应收账款体量较大
证券之星 · 08-28
圣湘生物(688289)2026年中报简析:净利润同比下降39.76%,公司应收账款体量较大
圣湘生物(688289)披露召开2026年第四次临时股东会的通知,8月27日股价上涨1.81%
证券之星 · 08-27
圣湘生物(688289)披露召开2026年第四次临时股东会的通知,8月27日股价上涨1.81%
股市必读:圣湘生物新发布《圣湘生物科技股份有限公司关于2026年半年度利润分配方案的公告》
证券之星 · 08-27
股市必读:圣湘生物新发布《圣湘生物科技股份有限公司关于2026年半年度利润分配方案的公告》
图解圣湘生物中报:第二季度单季净利润同比下降31.99%
证券之星 · 08-27
图解圣湘生物中报:第二季度单季净利润同比下降31.99%
破发股圣湘生物跌5.58% 上市见顶超募13亿西部证券保荐
中金财经 · 08-24
破发股圣湘生物跌5.58% 上市见顶超募13亿西部证券保荐
每周股票复盘:圣湘生物(688289)登革病毒检测试剂获注册证
证券之星 · 08-23
每周股票复盘:圣湘生物(688289)登革病毒检测试剂获注册证
破发股圣湘生物跌9.57% 上市见顶超募13亿西部证券保荐
中金财经 · 08-21
破发股圣湘生物跌9.57% 上市见顶超募13亿西部证券保荐
股市必读:圣湘生物新发布《圣湘生物科技股份有限公司关于自愿披露相关产品取得医疗器械注册证的公告》
证券之星 · 08-20
股市必读:圣湘生物新发布《圣湘生物科技股份有限公司关于自愿披露相关产品取得医疗器械注册证的公告》
圣湘生物最新公告:登革病毒和基孔肯雅病毒核酸检测试剂盒取得医疗器械注册证
证券之星 · 08-18
圣湘生物最新公告:登革病毒和基孔肯雅病毒核酸检测试剂盒取得医疗器械注册证
每周股票复盘:圣湘生物(688289)股东持股拟被司法执行涉0.99%股份
证券之星 · 08-16
每周股票复盘:圣湘生物(688289)股东持股拟被司法执行涉0.99%股份
破发股圣湘生物跌2.6% 上市见顶超募13亿西部证券保荐
中金财经 · 08-14
破发股圣湘生物跌2.6% 上市见顶超募13亿西部证券保荐
股市必读:圣湘生物新发布《圣湘生物科技股份有限公司关于原持股5%以上股东部分股份拟被司法强制执行的提示性公告》
证券之星 · 08-12
股市必读:圣湘生物新发布《圣湘生物科技股份有限公司关于原持股5%以上股东部分股份拟被司法强制执行的提示性公告》
圣湘生物最新公告:原持股5%以上股东部分股份拟被司法强制执行
证券之星 · 08-10
圣湘生物最新公告:原持股5%以上股东部分股份拟被司法强制执行
圣湘生物董秘黄强荣获第十二届金麒麟·金牌董秘荣誉
新浪财经 · 08-10
圣湘生物董秘黄强荣获第十二届金麒麟·金牌董秘荣誉
圣湘生物获得实用新型专利授权:“检测耗材和检测设备”
证券之星 · 07-31
圣湘生物获得实用新型专利授权:“检测耗材和检测设备”
圣湘生物获得发明专利授权:“裂解保存液、组合产品、试剂盒、核酸样本的制备方法和检测方法”
证券之星 · 07-18
圣湘生物获得发明专利授权:“裂解保存液、组合产品、试剂盒、核酸样本的制备方法和检测方法”
圣湘生物(688289)披露股份回购实施结果公告,7月17日股价下跌3.58%
证券之星 · 07-17
圣湘生物(688289)披露股份回购实施结果公告,7月17日股价下跌3.58%
圣湘生物:完成9998.07万元股份回购 用于员工持股或激励
格隆汇 · 07-17
圣湘生物:完成9998.07万元股份回购 用于员工持股或激励
加载更多
公司概况
公司名称:
圣湘生物科技股份有限公司
所属行业:
医药制造业
上市日期:
2020-08-28
主营业务:
圣湘生物科技股份有限公司的主营业务是诊断试剂及仪器的研发、生产与销售,并提供第三方医学检验服务;同时开展基因重组产品及生物制品的研发生产业务。公司的主要产品是诊断试剂、诊断仪器、生物类药品、检测服务。公司凭借“快速检测分子诊断技术攻关及在重大感染性疾病中的应用”项目斩获湖南省科学技术进步奖一等奖,也是本届唯一以独立完成单位拿下该一等奖的企业。
发行价格:
50.48
{"stockData":{"symbol":"688289","market":"SH","secType":"STK","nameCN":"圣湘生物","latestPrice":15.73,"timestamp":1788332401000,"preClose":15.81,"halted":0,"volume":4438411,"delay":0,"changeRate":-0.0051,"floatShares":575000000,"shares":575000000,"eps":0.2335,"marketStatus":"已收盘","change":-0.08,"latestTime":"09-02 15:00:01","open":15.69,"high":15.83,"low":15.58,"amount":69577500,"amplitude":0.0158,"askPrice":15.73,"askSize":59,"bidPrice":15.72,"bidSize":41,"shortable":0,"etf":0,"ttmEps":0.2335,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1788399000000},"marketStatusCode":5,"adr":0,"adjPreClose":15.81,"symbolType":"stock_kcb","openAndCloseTimeList":[[1788312600000,1788319800000],[1788325200000,1788332400000]],"highLimit":17.39,"lowLimit":14.23,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":574937804,"isCdr":false,"pbRate":1.29,"roa":"--","peRate":67.366167,"roe":"1.37%","epsLYR":0.34,"committee":0.103578,"marketValue":9044000000,"turnoverRate":0.0077,"status":1,"afterMarket":{"amount":0,"volume":0,"close":15.73,"buyVolume":0,"sellVolume":6000,"time":1788334437746,"indexStatus":"已收盘 09-02 15:30:00","preClose":15.81},"floatMarketCap":9044000000},"requestUrl":"/m/hq/s/688289","defaultTab":"news","newsList":[{"id":"2663700078","title":"圣湘生物:上半年流水线落地60余套","url":"https://stock-news.laohu8.com/highlight/detail?id=2663700078","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663700078?lang=zh_cn&edition=full","pubTime":"2026-08-31 15:37","pubTimestamp":1788161846,"startTime":"0","endTime":"0","summary":"证券之星消息,圣湘生物08月31日在投资者关系平台上答复投资者关心的问题。2026年上半年,公司大幅加大仪器装机资源投入力度,重点推进分子流水线、核酸一体机、测序仪的市场落地,加快分子POCT设备及配套试剂的注册取证,完善“中心实验室、常规科室、基层”三层仪器产品矩阵,仪器业务的装机、市场推广、注册取证均取得重要进展。上半年流水线落地60余套,测序仪落地40余台,一体机落地130余台。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100015987.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688289","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663067010","title":"每周股票复盘:圣湘生物(688289)Q2净利降31.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663067010","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663067010?lang=zh_cn&edition=full","pubTime":"2026-08-30 04:34","pubTimestamp":1788035650,"startTime":"0","endTime":"0","summary":"截至2026年8月28日收盘,圣湘生物报收于15.66元,较上周的15.78元下跌0.76%。本周,圣湘生物8月27日盘中最高价报16.05元。股本股东变化截至2026年6月30日,公司股东户数为2.09万户,较3月31日减少624户,减幅2.9%。其中第二季度单季度主营收入3.97亿元,同比上升0.98%;单季度归母净利润4827.8万元,同比下降31.99%;单季度扣非净利润403.96万元,同比下降91.1%。公司因注销回购股份4,450,202股,总股本将由579,388,006股变更为574,937,804股,注册资本相应减少。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083000001400.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688289","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662039343","title":"圣湘生物(688289)2026年中报简析:净利润同比下降39.76%,公司应收账款体量较大","url":"https://stock-news.laohu8.com/highlight/detail?id=2662039343","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662039343?lang=zh_cn&edition=full","pubTime":"2026-08-28 06:19","pubTimestamp":1787869147,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期圣湘生物发布2026年中报。截至本报告期末,公司营业总收入8.34亿元,同比下降3.95%,归母净利润9801.73万元,同比下降39.76%。本报告期圣湘生物公司应收账款体量较大,当期应收账款占最新年报归母净利润比达337.93%。去年的净利率为9.38%,算上全部成本后,公司产品或服务的附加值一般。本文数据来源于圣湘生物2026年中报,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800010983.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688289"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662011547","title":"圣湘生物(688289)披露召开2026年第四次临时股东会的通知,8月27日股价上涨1.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662011547","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662011547?lang=zh_cn&edition=full","pubTime":"2026-08-27 19:22","pubTimestamp":1787829748,"startTime":"0","endTime":"0","summary":"截至2026年8月27日收盘,圣湘生物报收于15.76元,较前一交易日上涨1.81%,最新总市值为90.61亿元。该股当日开盘15.32元,最高16.05元,最低15.3元,成交额达1.14亿元,换手率为1.26%。近日,圣湘生物科技股份有限公司发布《关于召开2026年第四次临时股东会的通知》。公告显示,公司定于2026年9月11日召开2026年第四次临时股东会,会议由董事会召集,采用现场投票与网络投票相结合的方式进行。股权登记日为2026年9月7日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700045613.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688289","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662747865","title":"股市必读:圣湘生物新发布《圣湘生物科技股份有限公司关于2026年半年度利润分配方案的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2662747865","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662747865?lang=zh_cn&edition=full","pubTime":"2026-08-27 05:10","pubTimestamp":1787778620,"startTime":"0","endTime":"0","summary":"圣湘生物科技股份有限公司关于召开2026年第四次临时股东会的通知将于2026年9月11日召开2026年第四次临时股东会,会议由董事会召集,采用现场投票与网络投票相结合的方式进行。圣湘生物科技股份有限公司关于2026年度“提质增效重回报”行动方案的半年度评估报告2026年上半年实现营收8.34亿元,净利0.98亿元,研发投入1.44亿元,占营收17.27%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700010155.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688289"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662460087","title":"图解圣湘生物中报:第二季度单季净利润同比下降31.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662460087","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662460087?lang=zh_cn&edition=full","pubTime":"2026-08-27 02:07","pubTimestamp":1787767644,"startTime":"0","endTime":"0","summary":"证券之星消息,圣湘生物2026年中报显示,上半年度公司主营收入8.34亿元,同比下降3.95%;归母净利润9801.73万元,同比下降39.76%;扣非净利润5370.43万元,同比下降60.48%;其中2026年第二季度,公司单季度主营收入3.97亿元,同比上升0.98%;单季度归母净利润4827.8万元,同比下降31.99%;单季度扣非净利润403.96万元,同比下降91.1%;负债率26.59%,投资收益-1411.31万元,财务费用-1535.75万元,毛利率71.32%。财报数据概要请见下图:本文数据来源于圣湘生物2026年中报,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700006243.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688289"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661221616","title":"破发股圣湘生物跌5.58% 上市见顶超募13亿西部证券保荐","url":"https://stock-news.laohu8.com/highlight/detail?id=2661221616","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661221616?lang=zh_cn&edition=full","pubTime":"2026-08-24 16:18","pubTimestamp":1787559482,"startTime":"0","endTime":"0","summary":"中国经济网北京8月24日讯 圣湘生物 今日收报14.90元,跌幅5.58%。该股目前处于破发状态。 圣湘生物于2020年8月28日在上交所科创板上市,发行数量为4,000万股,发行价格为50.48元/股,保荐机构为西部证券股份有限公司,保荐代表人为李锋、邹扬,联席主承销商为中信证券股份有限公司。 圣湘生物首次公开发行股票发行费用为1.50亿元,其中,西部证券和中信证券获得保荐及承销费用1.28亿元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260824/32344859.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0188","BK0276","IPOS","BK0239","002673","BK0183","BK0028","688289"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661721169","title":"每周股票复盘:圣湘生物(688289)登革病毒检测试剂获注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2661721169","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661721169?lang=zh_cn&edition=full","pubTime":"2026-08-23 01:35","pubTimestamp":1787420110,"startTime":"0","endTime":"0","summary":"截至2026年8月21日收盘,圣湘生物报收于15.78元,较上周的16.38元下跌3.66%。本周,圣湘生物8月20日盘中最高价报18.31元。本周关注点公司公告汇总:登革病毒和基孔肯雅病毒核酸检测试剂盒获国家药监局医疗器械注册证。公司公告汇总圣湘生物科技股份有限公司的登革病毒和基孔肯雅病毒核酸检测试剂盒近日获得国家药品监督管理局颁发的医疗器械注册证,注册证编号为国械注准20263401748,有效期至2031年8月16日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082300000182.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688289","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661668892","title":"破发股圣湘生物跌9.57% 上市见顶超募13亿西部证券保荐","url":"https://stock-news.laohu8.com/highlight/detail?id=2661668892","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661668892?lang=zh_cn&edition=full","pubTime":"2026-08-21 16:54","pubTimestamp":1787302445,"startTime":"0","endTime":"0","summary":"中国经济网北京8月21日讯 圣湘生物 今日收报15.78元,跌幅9.57%。该股目前处于破发状态。 圣湘生物首次公开发行股票募集资金总额为201,920.00万元,募集资金净额为186,926.98万元,较原计划多131,268.98万元。 圣湘生物首次公开发行股票发行费用为1.50亿元,其中,西部证券和中信证券获得保荐及承销费用1.28亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260821/32342830.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["688289","002673","BK0276","BK0239","IPOS","BK0028","BK0183","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660420292","title":"股市必读:圣湘生物新发布《圣湘生物科技股份有限公司关于自愿披露相关产品取得医疗器械注册证的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2660420292","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660420292?lang=zh_cn&edition=full","pubTime":"2026-08-20 02:54","pubTimestamp":1787165652,"startTime":"0","endTime":"0","summary":"截至2026年8月19日收盘,圣湘生物报收于15.65元,下跌1.51%,换手率1.01%,成交量5.84万手,成交额9198.47万元。公司公告汇总圣湘生物科技股份有限公司关于自愿披露相关产品取得医疗器械注册证的公告登革病毒和基孔肯雅病毒核酸检测试剂盒获得国家药品监督管理局颁发的医疗器械注册证,注册证编号为国械注准20263401748,有效期至2031年8月16日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082000002556.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688289","BK1574","BK1100","BK0239","BK1583","159883","09996"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660464688","title":"圣湘生物最新公告:登革病毒和基孔肯雅病毒核酸检测试剂盒取得医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2660464688","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660464688?lang=zh_cn&edition=full","pubTime":"2026-08-18 19:19","pubTimestamp":1787051974,"startTime":"0","endTime":"0","summary":"圣湘生物(688289.SH)公告称,公司产品登革病毒和基孔肯雅病毒核酸检测试剂盒(PCR-荧光探针法)近日收到国家药品监督管理局颁发的《医疗器械注册证》。该产品系国内首款获批上市的登革热与基孔肯雅热核酸联合检测产品。以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081800036720.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1100","159883","BK1574","BK1583","BK0239","09996","688289"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659175212","title":"每周股票复盘:圣湘生物(688289)股东持股拟被司法执行涉0.99%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2659175212","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659175212?lang=zh_cn&edition=full","pubTime":"2026-08-16 02:13","pubTimestamp":1786817590,"startTime":"0","endTime":"0","summary":"截至2026年8月14日收盘,圣湘生物报收于16.38元,较上周的15.71元上涨4.26%。本周,圣湘生物8月13日盘中最高价报17.03元。本次执行后,陈文义持股比例将由4.56%降至3.58%。公司已于2026年6月23日披露陈文义持股比例降至5%以下的相关公告。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081600000470.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688289"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659111753","title":"破发股圣湘生物跌2.6% 上市见顶超募13亿西部证券保荐","url":"https://stock-news.laohu8.com/highlight/detail?id=2659111753","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659111753?lang=zh_cn&edition=full","pubTime":"2026-08-14 17:16","pubTimestamp":1786698973,"startTime":"0","endTime":"0","summary":"中国经济网北京8月14日讯 圣湘生物 今日收报16.38元,跌幅2.62%。该股目前处于破发状态。 圣湘生物首次公开发行股票募集资金总额为201,920.00万元,募集资金净额为186,926.98万元,较原计划多131,268.98万元。 圣湘生物首次公开发行股票发行费用为1.50亿元,其中,西部证券和中信证券获得保荐及承销费用1.28亿元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260814/32335406.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["IPOS","BK0183","688289","BK0276","BK0239","002673","BK0188","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658700917","title":"股市必读:圣湘生物新发布《圣湘生物科技股份有限公司关于原持股5%以上股东部分股份拟被司法强制执行的提示性公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2658700917","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658700917?lang=zh_cn&edition=full","pubTime":"2026-08-12 02:29","pubTimestamp":1786472951,"startTime":"0","endTime":"0","summary":"公司公告汇总圣湘生物科技股份有限公司关于原持股5%以上股东部分股份拟被司法强制执行的提示性公告圣湘生物科技股份有限公司于近日收到湖南省株洲市中级人民法院下发的《协助执行通知书》,公司原持股5%以上股东陈文义所持部分股份拟被司法强制执行。公司已于2026年6月23日披露陈文义持股比例降至5%以下的相关公告。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081200002277.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688289","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658101987","title":"圣湘生物最新公告:原持股5%以上股东部分股份拟被司法强制执行","url":"https://stock-news.laohu8.com/highlight/detail?id=2658101987","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658101987?lang=zh_cn&edition=full","pubTime":"2026-08-10 18:20","pubTimestamp":1786357212,"startTime":"0","endTime":"0","summary":"圣湘生物(688289.SH)公告称,公司原持股5%以上股东陈文义所持部分股份拟被司法强制执行。湖南省株洲市中级人民法院拟通过大宗交易或集中竞价方式分批次卖出其持有的公司无限售流通股合计571万股,占公司总股本的0.99%,减持期限不晚于2027年12月30日。本次执行后,陈文义持股数量将由2642.74万股降至2071.74万股,持股比例由4.56%降至3.58%。该事项不会影响公司控制权稳定,不会对日常经营造成影响。以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081000026170.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688289","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658985912","title":"圣湘生物董秘黄强荣获第十二届金麒麟·金牌董秘荣誉","url":"https://stock-news.laohu8.com/highlight/detail?id=2658985912","media":"新浪财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658985912?lang=zh_cn&edition=full","pubTime":"2026-08-10 15:24","pubTimestamp":1786346640,"startTime":"0","endTime":"0","summary":"登录新浪财经APP 搜索查看更多考评等级专题:专题:第十二届金麒麟·金牌董秘及优秀证代荣誉榜单揭晓!8月10日,新浪财经第十二届金麒麟金牌董秘榜单正式揭晓。圣湘生物董事会秘书黄强凭借扎实的合规治理能力、成熟的投资者关系运营、长期稳健的资本价值传递表现,荣耀加冕第十二届金麒麟金牌董秘。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/roll/2026-08-10/doc-inimvhfm1300872.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["688289","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655388977","title":"圣湘生物获得实用新型专利授权:“检测耗材和检测设备”","url":"https://stock-news.laohu8.com/highlight/detail?id=2655388977","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655388977?lang=zh_cn&edition=full","pubTime":"2026-07-31 03:26","pubTimestamp":1785439583,"startTime":"0","endTime":"0","summary":"证券之星消息,根据天眼查APP数据显示圣湘生物新获得一项实用新型专利授权,专利名为“检测耗材和检测设备”,专利申请号为CN202521291710.4,授权日为2026年7月31日。采用上述的检测耗材,能够防止第一试剂中的强碱性或强腐蚀性物质将隔膜腐蚀的技术问题,提高检测精度和检测效果。今年以来圣湘生物新获得专利授权38个,较去年同期增加了40.74%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026073100003999.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688289","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652280885","title":"圣湘生物获得发明专利授权:“裂解保存液、组合产品、试剂盒、核酸样本的制备方法和检测方法”","url":"https://stock-news.laohu8.com/highlight/detail?id=2652280885","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652280885?lang=zh_cn&edition=full","pubTime":"2026-07-18 03:24","pubTimestamp":1784316257,"startTime":"0","endTime":"0","summary":"证券之星消息,根据天眼查APP数据显示圣湘生物新获得一项发明专利授权,专利名为“裂解保存液、组合产品、试剂盒、核酸样本的制备方法和检测方法”,专利申请号为CN202411996692.X,授权日为2026年7月17日。采用本申请的制备方法的核酸样本,无需清洗,即可直接进行PCR等检测,操作简单,适用于急诊等场合。今年以来圣湘生物新获得专利授权35个,较去年同期增加了66.67%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071800002437.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688289","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652128137","title":"圣湘生物(688289)披露股份回购实施结果公告,7月17日股价下跌3.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2652128137","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652128137?lang=zh_cn&edition=full","pubTime":"2026-07-17 22:49","pubTimestamp":1784299751,"startTime":"0","endTime":"0","summary":"截至2026年7月17日收盘,圣湘生物报收于15.34元,较前一交易日下跌3.58%,最新总市值为88.88亿元。该股当日开盘15.83元,最高15.97元,最低15.24元,成交额达1.37亿元,换手率为1.53%。近日,圣湘生物科技股份有限公司发布《关于股份回购实施结果的公告》。回购股份将用于员工持股计划或股权激励,存放于回购专用证券账户期间不享有相关股东权利。若三年内未使用完毕,将依法注销。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071700045257.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688289","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652400542","title":"圣湘生物:完成9998.07万元股份回购 用于员工持股或激励","url":"https://stock-news.laohu8.com/highlight/detail?id=2652400542","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652400542?lang=zh_cn&edition=full","pubTime":"2026-07-17 19:25","pubTimestamp":1784287542,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0239","688289"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1788385810398,"stockEarnings":[{"period":"1week","weight":0.0161},{"period":"1month","weight":0.0032},{"period":"3month","weight":0.0546},{"period":"6month","weight":-0.1265},{"period":"1year","weight":-0.2213},{"period":"ytd","weight":-0.1528}],"compareEarnings":[{"period":"1week","weight":0.0074},{"period":"1month","weight":0.0346},{"period":"3month","weight":-0.0287},{"period":"6month","weight":-0.0443},{"period":"1year","weight":0.0216},{"period":"ytd","weight":-0.0069}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"圣湘生物科技股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"20869人(较上一季度减少2.90%)","perCapita":"27549股","listingDate":"2020-08-28","address":"湖南省长沙市岳麓区高新技术产业开发区麓松路680号","registeredCapital":"57493万元","survey":" 圣湘生物科技股份有限公司的主营业务是诊断试剂及仪器的研发、生产与销售,并提供第三方医学检验服务;同时开展基因重组产品及生物制品的研发生产业务。公司的主要产品是诊断试剂、诊断仪器、生物类药品、检测服务。公司凭借“快速检测分子诊断技术攻关及在重大感染性疾病中的应用”项目斩获湖南省科学技术进步奖一等奖,也是本届唯一以独立完成单位拿下该一等奖的企业。","listedPrice":50.48},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"圣湘生物(688289)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供圣湘生物(688289)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"圣湘生物,688289,圣湘生物股票,圣湘生物股票老虎,圣湘生物股票老虎国际,圣湘生物行情,圣湘生物股票行情,圣湘生物股价,圣湘生物股市,圣湘生物股票价格,圣湘生物股票交易,圣湘生物股票购买,圣湘生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"圣湘生物(688289)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供圣湘生物(688289)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}